HyGIeaCare Procedure for Chronic Constipation

Status Withdrawn

Clinical Trial Summary

To assess the safety and clinical effectiveness of using the FDA cleared HyGIeaCare System to relieve constipation in patients not responding to standard laxative treatment. Each patient will serve as their own control by comparing their bowel habits in a diary 4 weeks prior to colon irrigation to the bowel habits in their diary 4 weeks post colon irrigation.

Clinical Trial Description

This study has a single center, prospective, open label design. Patients will serve as their own control.

The population will include patients with chronic constipation according to Rome III criteria who failed to improve with currently available therapy (osmotic and stimulant laxatives, used for at least one month at recommended dose).

Once patients are consented to participate in the study, they will complete the Gastrointestinal Symptom Severity Index (GISSI) questionnaire. Patients will complete the 4 Week Bowel Movement Diary and 4 Week Medication Use Diary for the 4-weeks prior to their HyGIeaCare procedure. The Medication Use Diary will include any rescue medications taken above and beyond what patients are taking as part of their constipation regimen.

The patient will schedule their HyGIeaCare procedure directly with the HyGIeaCare Clinic. The nurse manager can be reached at 480-750-2333. The clinic is located at 4001 E. Baseline Road, Gilbert, AZ. The nurse manager will provide the patient with any instructions needed prior to their HyGIeaCare procedure. HyGIeaCare will furnish the principle investigator with the complete patient care records after the irrigation procedure has been completed.

Following the 4 weeks post the patient's HyGIeaCare procedure, the patient will complete a new 4 Week Bowel Movement Diary and 4 Week Medication Use Diary for the 4-weeks post their HyGIeaCare procedure. The patient will bring these documents to their clinic follow-up visit. At this visit the patient will complete another GISSI questionnaire and will be evaluated for possible adverse events.

Patient data will be collected on hard copy case report forms (CRFs) and then entered into an electronic database. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03335969
Study type	Interventional
Source	HyGIeaCare, Inc.
Contact
Status	Withdrawn
Phase	N/A
Start date	March 1, 2018
Completion date	March 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05032534` - Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence	N/A
Completed	`NCT04587635` - Evaluation of Changes in Bowel Movement Frequency Following the Consumption of PHGG in Adults With Constipation	N/A
Completed	`NCT03821532` - Adherence/Outcomes After Use of Constipation Action Plan	N/A
Recruiting	`NCT06122558` - Efficacy of Probiotic Against Functional Constipation	Phase 2
Recruiting	`NCT04086134` - Physiological, Microbiological and Metabolomic Effects of Fruit Products	N/A
Recruiting	`NCT01587846` - Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children	Phase 3
Recruiting	`NCT05496543` - Acupuncture for Functional Constipation in Older Adults	N/A
Completed	`NCT05447481` - Evaluation of the Effect of Chicory Inulin-type Fructans in Constipated Adults	N/A
Completed	`NCT05035784` - RCE With FMT in the Treatment of Childhood Constipation	N/A
Recruiting	`NCT06221722` - Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
Suspended	`NCT04306939` - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Recruiting	`NCT05823259` - The Impact of Respiratory Muscle Training and Patient Education on Chronic Constipation Outcomes	N/A
Withdrawn	`NCT05321953` - The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation	N/A
Active, not recruiting	`NCT05363553` - Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study	N/A
Recruiting	`NCT06031025` - Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
Recruiting	`NCT05432453` - The Relationship Between Functional Constipation and Sacroiliac Joint Dysfunction
Not yet recruiting	`NCT05191810` - Efficacy of Educational Intervention as Supporting Element in the Treatment of Functional Constipation in Children	N/A
Not yet recruiting	`NCT06100055` - The ReVo Study: Low-volume vs High-volume Rectal Irrigation	N/A
Recruiting	`NCT04148248` - A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation
Completed	`NCT03078634` - The Multi-disciplinary Treatment of Functional Gut Disorders Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.